Healthcare -
Biotechnology - NASDAQ - US
$ 40.0
-2.08 %
$ 3.69 B
Market Cap
-6.3
P/E
RARE - TOTAL EQUITY
Total Equity RARE - Ultragenyx Pharmaceutical Inc.
275 M
LAST VALUE
-45.36%
2 YEAR CAGR
-14.67%
5 YEAR CAGR
18.58%
10 YEAR CAGR